BackXeris Biopharma Holdings Overview

Xeris Biopharma Holdings Total Assets

Xeris Biopharma Holdings's total assets is $410M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$411.90M
23.07% YoYΔ $77.22M vs prior year quarter

Peer trimmed avg / median

Loading

Xeris Biopharma Holdings Total Assets History

Loading

Xeris Biopharma Holdings vs. peers: Total Assets Comparison

Loading

Xeris Biopharma Holdings Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Xeris Biopharma Holdings (XERS) FAQ

As of the most recent data (June 2026), XERS shows a total assets of $410M. That compares with $330M in the prior-year period — up 23.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, XERS's total assets is now $410M (was $330M) — a 23.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Xeris Biopharma Holdings is outperforming or lagging.

Tracking XERS's total assets over time shows whether Xeris Biopharma Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $410M That compares with $330M in the prior-year period — up 23.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Xeris Biopharma Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $410M) with ownership activity and broader fundamentals.

Xeris Biopharma Holdings's total assets is $410M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.